131 related articles for article (PubMed ID: 21220838)
1. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes. 2008 activity.
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2010; 34(5-6 Suppl 4):73-80. PubMed ID: 21220838
[TBL] [Abstract][Full Text] [Related]
2. Quality of colposcopy and treatment--data from the national survey of Italian organised cervical screening programmes: 2006 activity.
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2009; 33(3 Suppl 2):75-82. PubMed ID: 19776488
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening in Italy: quality of colposcopy and treatment. 2009 activity.
Ronco G; Volante R; Giubilato P
Epidemiol Prev; 2011; 35(5-6 Suppl 5):78-86. PubMed ID: 22166351
[TBL] [Abstract][Full Text] [Related]
4. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes.
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2007; 31(2-3 Suppl 2):61-8. PubMed ID: 17824363
[TBL] [Abstract][Full Text] [Related]
5. [Cervical cancer screening in Italy: quality of colposcopy and treatment. 2010 activity].
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2012; 36(6 Suppl 1):78-86. PubMed ID: 23293272
[TBL] [Abstract][Full Text] [Related]
6. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes.
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2008; 32(2 Suppl 1):69-76. PubMed ID: 18773525
[TBL] [Abstract][Full Text] [Related]
7. National survey of the quality of 2nd level in screening for cervical cancer.
Volante R; Ronco G
Epidemiol Prev; 2006; 30(1 Suppl 3):51-7. PubMed ID: 16937846
[TBL] [Abstract][Full Text] [Related]
8. Extension of organized cervical cancer screening programmes in Italy and their process indicators, 2011-2012 activity.
Ronco G; Giubilato P; Carozzi F; Maia G; Giorgi Rossi P; Zappa M;
Epidemiol Prev; 2015; 39(3 Suppl 1):61-76. PubMed ID: 26405778
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
10. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
11. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
12. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2007; 31(2-3 Suppl 2):33-47. PubMed ID: 17824361
[TBL] [Abstract][Full Text] [Related]
13. Activity level and process indicators of organised programmes for cervical cancer screening in Italy.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2006; 30(1 Suppl 3):27-40. PubMed ID: 16937844
[TBL] [Abstract][Full Text] [Related]
14. High-grade CIN on cervical biopsy and predictors of the subsequent cone histology results in women undergoing immediate conization.
Giannella L; Mfuta K; Gardini G; Rubino T; Fodero C; Prandi S
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():68-74. PubMed ID: 25656975
[TBL] [Abstract][Full Text] [Related]
15. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
16. The use of carbon-dioxide laser surgery in the treatment of intraepithelial neoplasia of the uterine cervix.
Favalli G; Lomini M; Schreiber C; Ciravolo G; Junasevic J; Pecorelli S; Bianchi UA
Przegl Lek; 1999; 56(1):58-64. PubMed ID: 10375929
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 Years.
Silver MI; Gage JC; Schiffman M; Fetterman B; Poitras NE; Lorey T; Cheung LC; Katki HA; Locke A; Kinney WK; Castle PE
Cancer Prev Res (Phila); 2018 Mar; 11(3):165-170. PubMed ID: 29437696
[TBL] [Abstract][Full Text] [Related]
18. Management of women with low grade cytology: how reassuring is a normal colposcopy examination?
Cruickshank ME; Cotton SC; Sharp L; Smart L; Walker LG; Little J;
BJOG; 2015 Feb; 122(3):380-6. PubMed ID: 24947656
[TBL] [Abstract][Full Text] [Related]
19. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
[TBL] [Abstract][Full Text] [Related]
20. Invasive cervical cancer audit: why cancers developed in a high-risk population with an organised screening programme.
Herbert A; Anshu ; Culora G; Dunsmore H; Gupta SS; Holdsworth G; Kubba AA; McLean E; Sim J; Raju KS
BJOG; 2010 May; 117(6):736-45. PubMed ID: 20184570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
